Personalis, Inc. (PSNL)

USD 4.16

(7.77%)

Revenue Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual revenue in 2023 was 73.48 Million USD , up 12.97% from previous year.
  • Personalis, Inc.'s latest quarterly revenue in 2024 Q1 was 19.52 Million USD , down -0.76% from previous quarter.
  • Personalis, Inc. reported a annual revenue of 65.04 Million USD in annual revenue 2022, down -23.92% from previous year.
  • Personalis, Inc. reported a annual revenue of 85.49 Million USD in annual revenue 2021, up 8.7% from previous year.
  • Personalis, Inc. reported a quarterly revenue of 19.52 Million USD for 2024 Q1, down -0.76% from previous quarter.
  • Personalis, Inc. reported a quarterly revenue of 16.69 Million USD for 2023 Q2, down -11.46% from previous quarter.

Annual Revenue Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Revenue of Personalis, Inc. (2023 - 2017)

Year Revenue Revenue Growth
2023 73.48 Million USD 12.97%
2022 65.04 Million USD -23.92%
2021 85.49 Million USD 8.7%
2020 78.64 Million USD 20.61%
2019 65.2 Million USD 72.62%
2018 37.77 Million USD 302.15%
2017 9.39 Million USD 0.0%

Peer Revenue Comparison of Personalis, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -135.147%
Biodesix, Inc. 49.08 Million USD -49.695%
bioAffinity Technologies, Inc. 2.53 Million USD -2801.521%
Castle Biosciences, Inc. 219.78 Million USD 66.567%
DarioHealth Corp. 20.35 Million USD -261.051%
Exact Sciences Corporation 2.49 Billion USD 97.06%
IDEXX Laboratories, Inc. 3.66 Billion USD 97.993%
Illumina, Inc. 4.5 Billion USD 98.369%
Intelligent Bio Solutions Inc. 3.11 Million USD -2261.381%
iSpecimen Inc. 9.92 Million USD -640.125%
Standard BioTools Inc. 106.34 Million USD 30.9%
23andMe Holding Co. 219.63 Million USD 66.544%
Medpace Holdings, Inc. 1.88 Billion USD 96.104%
NeoGenomics, Inc. 591.64 Million USD 87.58%
Inotiv, Inc. 572.42 Million USD 87.163%
Psychemedics Corporation 22.09 Million USD -232.523%
Prenetics Global Limited 21.74 Million USD -237.957%
Precipio, Inc. 15.19 Million USD -383.523%
RadNet, Inc. 1.61 Billion USD 95.455%
Sotera Health Company 1.04 Billion USD 92.997%
Star Equity Holdings, Inc. 45.78 Million USD -60.491%
Exagen Inc. 52.54 Million USD -39.836%
Natera, Inc. 1.08 Billion USD 93.212%
Aspira Women's Health Inc. 9.15 Million USD -702.72%
Neogen Corporation 924.22 Million USD 92.049%
Myriad Genetics, Inc. 678.4 Million USD 89.168%
ICON Public Limited Company 8.12 Billion USD 99.095%
Bionano Genomics, Inc. 36.11 Million USD -103.458%
CareDx, Inc 280.32 Million USD 73.787%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 76.522%
Guardant Health, Inc. 563.94 Million USD 86.97%
BioNexus Gene Lab Corp. 9.77 Million USD -652.046%
Fulgent Genetics, Inc. 289.21 Million USD 74.593%
Sera Prognostics, Inc. 306 Thousand USD -23913.399%
OPKO Health, Inc. 863.49 Million USD 91.49%
Applied DNA Sciences, Inc. 13.36 Million USD -449.701%
Star Equity Holdings, Inc. 45.78 Million USD -60.491%
MDxHealth SA 70.19 Million USD -4.684%
Prenetics Global Limited 21.74 Million USD -237.957%
ENDRA Life Sciences Inc. - USD -Infinity%
Mainz Biomed B.V. 895.47 Thousand USD -8105.776%
Trinity Biotech plc 56.83 Million USD -29.295%
Neuronetics, Inc. 71.34 Million USD -2.99%
bioAffinity Technologies, Inc. 2.53 Million USD -2801.521%